FDA Inspection 1063079 — David P. Walling, Ph.D.
The FDA completed an inspection of David P. Walling, Ph.D. on March 19, 2018 in Garden Grove, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Garden Grove, CA (United States)
Additional Details
Clinical Investigator (CI)